Failure-mode index

Search what already failed

A searchable index of real negative results, null findings, and replication failures from the published literature — so you can learn what didn't work before repeating it.

All Replication Failure Negative / Null Result Report Failed Experiment Report Abandoned Hypothesis Methods Dead-End Short Note Null Dataset Protocol

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record (title, authors, DOI) compiled from open scholarly databases, with the abstract shown in full only where the paper is openly licensed (e.g. Creative Commons); otherwise a short excerpt is shown for reference under fair use. WASTE classifies each work by failure type; classifications are automated and approximate.

By fieldMedicine 12,301 Computer Science 753 Biochemistry, Genetics and Molecular Biology 443 Social Sciences 312 Psychology 309 Physics 280 Neuroscience 258 Economics, Econometrics and Finance 209 Environmental Science 186 Mathematics 161 Agricultural and Biological Sciences 151 Engineering 150

96 results for "SARS-CoV-2" · page 4 of 4

Negative / Null Result Report

Incidence of Postoperative Pulmonary Complications in Patients with Prior COVID-19 Infection: A Lebanese Prospective Cohort Study

Hadi CE, Dailaty AA, Sobh AH et al. · 2025 · Preprint

Abstract Background Postoperative pulmonary complications (PPCs) remain a major determinant of morbidity after noncardiac surgery. Whether prior SARS-CoV-2 infection independently heightens PPC risk in the contemporary, highly vaccinated,…

View details →DOI: 10.21203/rs.3.rs-8100907/v1

Negative / Null Result ReportMedicine

COVID-19 infection prior to the onset of type 1 diabetes does not impair beta-cell function: a two-year nationwide follow-up study.

Bjerregaard-Andersen M, Hostrup PE, Kolnes KJ et al. · 2026 · BMC endocrine disorders

Background A possible association between infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and type 1 diabetes (T1D) development has been reported. Whether SARS-CoV-2 infection affects beta-cell loss in T1D…

View details →DOI: 10.1186/s12902-026-02358-z

Negative / Null Result ReportMedicine

Maternal SARS-CoV-2 Antibodies in Mink Kits: Dynamics of Passive Immunity and Implications for Silent Farm-Wide Transmission Following Virus Re-Incursion.

Thomou Z, Dovas CI, Poutahidis T et al. · 2026 · Viral immunology

Maternal antibodies protect mink kits early in life, but their duration and impact on subsequent SARS-CoV-2 exposure remain unclear. We longitudinally characterized passive immunity in kits born to mothers previously infected with lineage…

View details →DOI: 10.1177/08828245261444539

Negative / Null Result Report

Incidence of SARS-CoV-2 in Patients with Rheumatic Diseases on Hydroxychloroquine, Compared with the Incidence of SARS-CoV-2 in Controls on a Prophylactic Dose of Hydroxychloroquine

Jordhani M, Ruci D, Jordhani P et al. · 2025 · Preprint

Background: Hydroxychloroquine (HCQ) is a disease-modifying antirheumatic drug used in rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and other autoimmune diseases. Although HCQ reduces SARS-CoV-2 replication in vitro at…

View details →DOI: 10.20944/preprints202509.1673.v1

Negative / Null Result ReportOpen accessMedicine

Convalescent plasma therapy for COVID-19 prophylaxis in adults early post-hematopoietic stem cell transplantation: one-year outcomes from a randomized controlled trial.

Cao Y, Li Q, Guo W et al. · 2025 · Frontiers in immunology

To evaluate the efficacy of COVID-19 convalescent plasma (CCP) in preventing SARS-CoV-2 infection in hematopoietic stem cell transplantation (HSCT) recipients during the early post-transplant period, a single-center, randomized controlled…

View details →DOI: 10.3389/fimmu.2025.1626775

Negative / Null Result ReportOpen accessMedicine

A Pilot, Randomised, Placebo-Controlled, Double-Blind Trial of a Single Oral Dose of Ivermectin for Post-Exposure Prophylaxis of SARS-CoV-2.

Wagstaff KM, Stein MS, Herschtal A et al. · 2025 · Pharmaceutics

Background: The efficacy of a single oral dose of Ivermectin as prophylaxis for SARS-CoV-2 is uncertain. This trial sought to evaluate the effectiveness of a single oral low dose of Ivermectin to prevent SARS-CoV-2 infection or reduce…

View details →DOI: 10.3390/pharmaceutics17091205